Inspira Technologies Partners with Glo-Med for 531 ART Device Deployment in Gulf States
Ticker: IINNW · Form: 6-K · Filed: Jan 30, 2024 · CIK: 1837493
| Field | Detail |
|---|---|
| Company | Inspira Technologies Oxy B.H.N. LTD (IINNW) |
| Form Type | 6-K |
| Filed Date | Jan 30, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Complexity: simple
Sentiment: bullish
Topics: strategic-agreement, international-expansion, medical-devices
TL;DR
**Inspira just landed a deal to deploy 531 ART devices in the Gulf States, big market expansion!**
AI Summary
Inspira Technologies Oxy B.H.N. Ltd. announced on January 30, 2024, a strategic agreement with Glo-Med to deploy 531 ART devices in the Gulf States. This partnership marks Inspira's entry into a new market, potentially expanding its revenue streams and global presence. For investors, this signifies a concrete step towards commercializing its medical technology and could lead to increased sales and market share, making the stock more attractive.
Why It Matters
This agreement opens a new market for Inspira Technologies, potentially boosting future revenue and demonstrating progress in commercializing its medical devices.
Risk Assessment
Risk Level: medium — While promising, the success of the deployment and market penetration in the Gulf States still carries execution risks and depends on regulatory approvals and adoption rates.
Analyst Insight
A smart investor would monitor the progress of the Glo-Med partnership and the actual deployment of the 531 ART devices, looking for updates on revenue generation and market penetration in the Gulf States, as this could signal significant growth potential.
Key Numbers
- 531 — ART Devices (number of devices to be deployed under the agreement)
- January 30, 2024 — Agreement Date (date the strategic agreement was signed and announced)
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — the registrant and medical device company
- Glo-Med (company) — strategic partner for deployment in Gulf States
- Dagi Ben-Noon (person) — Chief Executive Officer of Inspira Technologies
- Gulf States (geographic_location) — new market for device deployment
Forward-Looking Statements
- Inspira Technologies will see increased revenue from the deployment of ART devices in the Gulf States. (Inspira Technologies Oxy B.H.N. Ltd.) — medium confidence, target: within 12-24 months
- The partnership with Glo-Med will lead to further expansion opportunities for Inspira Technologies in other international markets. (Inspira Technologies Oxy B.H.N. Ltd.) — low confidence, target: within 2-3 years
FAQ
What is the primary purpose of this 6-K filing by Inspira Technologies Oxy B.H.N. Ltd.?
The primary purpose of this 6-K filing is to report a press release issued on January 30, 2024, titled 'Inspira Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 ART Devices,' which is furnished as Exhibit 99.1.
Which specific parts of the press release are incorporated by reference into Inspira Technologies' registration statements?
The first three paragraphs and the section titled 'Forward-Looking Statements' in the press release are incorporated by reference into the Registrant’s Registration Statements on Form F-3 (Registration No. 333-266748) and Form S-8 (Registration No. 333-259057).
Who signed this 6-K report on behalf of Inspira Technologies Oxy B.H.N. Ltd.?
The 6-K report was signed by Dagi Ben-Noon, the Chief Executive Officer of Inspira Technologies Oxy B.H.N. Ltd., on January 30, 2024.
What is the Commission File Number for Inspira Technologies Oxy B.H.N. Ltd.?
The Commission File Number for Inspira Technologies Oxy B.H.N. Ltd. is 001-40303.
What type of annual report does Inspira Technologies Oxy B.H.N. Ltd. file?
Inspira Technologies Oxy B.H.N. Ltd. indicates by check mark that it files annual reports under cover of Form 20-F.
Filing Stats: 304 words · 1 min read · ~1 pages · Grade level 8.8 · Accepted 2024-01-30 08:40:02
Filing Documents
- ea192468-6k_inspiratech.htm (6-K) — 11KB
- ea192468ex99-1_inspiratech.htm (EX-99.1) — 11KB
- 0001213900-24-007607.txt ( ) — 23KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: January 30, 2024 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2